sotorasib,panitumumab
takeda,amgen
['rectal', 'lumakras', 'sotorasib', 'panitumumab', 'vectibix', 'colorectal', 'amgen', '$amgn']
#amgen reported that #lumakras (#sotorasib) combined with #vectibix (#panitumumab) shows confirmed 30% objective response rate in patients with #krasg12c #mutated #metastatic #colorectalcancer #esmo22 $amgn 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.